Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of the expression and potential molecular mechanism of interleukin-1 receptor antagonist (IL1RN) in papillary thyroid cancer via bioinformatics methods.

BMC cancer - 25 Nov 2020

Xie Zhenyu, Li Xin, He Yuzhen, Wu Song, Wang Shiyue, Sun Jianjian, He Yuchen, Lun Yu, Xin Shijie, Zhang Jian

Abstract excerpt

BACKGROUND: Interleukin-1 receptor antagonist (IL1RN) has been reported as a biomarker of many cancers. However, the biological function of IL1RN in papillary thyroid carcinoma (PTC) remains undetermined. METHODS: We obtained IL1RN expression data from The Cancer Genome Atlas (TCGA) database. Enrichment analysis of coexpressed genes and IL1RN methylation analysis were performed via LinkedOmics. The correlations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Papillary
Share to Computational Biology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Methylation

Share to Follow-Up Studies

Share to Gene Expression Regulation, Neoplastic

Share to Interleukin 1 Receptor Antagonist Protein

Share to Survival Rate

Share to Thyroid Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 33238942
DOI: 10.1186/s12885-020-07620-8
PMCID: PMC7687764

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of the expression and potential molecular mechanism of interleukin-1 receptor antagonist (IL1RN) in papillary thyroid cancer via bioinformatics methods.PMID 33238942Read ↗

Analysis of the expression and potential molecular mechanism of interleukin-1 receptor antagonist (IL1RN) in papillary thyroid cancer via bioinformatics methodsSemantic proximity Read ↗

Analysis of the expression and potential molecular mechanism of interleukin-1 receptor antagonist (IL1RN) in papillary thyroid cancer via bioinformatics methodsSemantic proximity Read ↗

Development an Immune-Associated LncRNA Prognostic Index for Papillary Thyroid CancerSemantic proximity Read ↗

Analysis of the Prognostic Value and Potential Molecular Mechanisms of TREM-1 Overexpression in Papillary Thyroid Cancer via Bioinformatics Methods.Semantic proximity Read ↗

A Novel Signature to Predict Thyroid Cancer Prognosis and Immune Landscape Using Immune-Related LncRNA PairsSemantic proximity Read ↗

Identification and validation of an immune-related prognostic signature and key gene in papillary thyroid carcinomaSemantic proximity Read ↗

Construction and Validation of an Immune-Related lncRNA Prognosis Model for Thyroid CancerSemantic proximity Read ↗

Construction and Validation of an Immune-Related lncRNA Prognosis Model for Thyroid CancerSemantic proximity Read ↗

In silico evaluation of the role of the long non-coding RNA LINC00092 in thyroid cancer progression ; regulation of the miR-34a-5p/RCAN1 axisSemantic proximity Read ↗

Using Tumor-Infiltrating Immune Cells and a ceRNA Network Model to Construct a Prognostic Analysis Model of Thyroid CarcinomaSemantic proximity Read ↗

Identification of key genes of papillary thyroid carcinoma by integrated bioinformatics analysisSemantic proximity Read ↗

Identification of lncRNAs and immune-related prognostic genes as thyroid cancer microenvironment biomarkersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.